K Number
K032459
Device Name
PROFILE 1320 LASER SYSTEM
Manufacturer
Date Cleared
2004-03-09

(211 days)

Product Code
Regulation Number
878.4810
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
The Sciton, Inc. Profile 1320 Laser is intended for use in general surgery and dermatology for the incision, excision, ablation, vaporization, coagulation, with hemostasis of soft tissue. It is indicated for the treatment of fine lines and wrinkles. It is also indicated for the treatment of back acne and atrophic acne scars.
Device Description
Profile 1320 Laser System is an Nd:YAG laser producing emission at a wavelength of 1320 nm. It consists of a laser console, internal computer, control panel and displav. an optical delivery system comprised of an articulated arm and a handpiece or scanner with cooling capability, and a footswitch.
More Information

Not Found

No
The summary describes a laser system with standard components and makes no mention of AI or ML capabilities, image processing, or data sets for training/testing.

Yes
The device is intended for the treatment of fine lines and wrinkles, back acne, and atrophic acne scars, which are all conditions that affect the body's structure or function.

No

The device description clearly states its intended use is for "incision, excision, ablation, vaporization, coagulation, with hemostasis of soft tissue" and treating "fine lines and wrinkles," "back acne and atrophic acne scars." These are all therapeutic applications, not diagnostic ones.

No

The device description explicitly states it consists of a laser console, internal computer, control panel, display, optical delivery system (articulated arm, handpiece/scanner), and footswitch, all of which are hardware components.

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use: The intended use clearly describes a device used for surgical and dermatological procedures directly on the patient's body (incision, excision, ablation, vaporization, coagulation of soft tissue, treatment of fine lines, wrinkles, back acne, and acne scars).
  • Device Description: The description details a laser system with components like a console, articulated arm, handpiece, and footswitch, all designed for direct application to the patient.
  • Lack of IVD Characteristics: There is no mention of analyzing samples taken from the human body (like blood, urine, tissue samples, etc.) or providing information about a physiological state, health, or disease. IVDs are used to perform tests in vitro (outside the body).

Therefore, the Sciton, Inc. Profile 1320 Laser is a therapeutic and surgical device, not an in vitro diagnostic device.

N/A

Intended Use / Indications for Use

The Sciton, Inc. Profile 1320 Laser is intended for use in general surgery and dermatology for the incision, excision, ablation, vaporization, coagulation, with hemostasis of soft tissue. It is indicated for the treatment of fine lines and wrinkles. It is also indicated for the treatment of back acne and atrophic acne scars.

Product codes

GEX

Device Description

Profile 1320 Laser System is an Nd:YAG laser producing emission at a wavelength of 1320 nm. It consists of a laser console, internal computer, control panel and display, an optical delivery system comprised of an articulated arm and a handpiece or scanner with cooling capability, and a footswitch.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Not Found

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies

Not Found

Key Metrics

Not Found

Predicate Device(s)

K022466, K022381, K031184, K030453, K022817, K014035, K012982, K022884, K014128, K013825

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 878.4810 Laser surgical instrument for use in general and plastic surgery and in dermatology.

(a)
Identification. (1) A carbon dioxide laser for use in general surgery and in dermatology is a laser device intended to cut, destroy, or remove tissue by light energy emitted by carbon dioxide.(2) An argon laser for use in dermatology is a laser device intended to destroy or coagulate tissue by light energy emitted by argon.
(b)
Classification. (1) Class II.(2) Class I for special laser gas mixtures used as a lasing medium for this class of lasers. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807 of this chapter, subject to the limitations in § 878.9.

0

K032459

Attachment IV

510(k) Summary

Submitter:Sciton, Inc.
Address:845 Commercial Street, Palo Alto, CA 94303
Phone:(650) 493-9155
Fax :(650) 493-9146
Contact Person:Jay M. Patel, Director of Regulatory Affairs
Date Prepared:August 1, 2003
Device Trade Name:Profile 1320 Laser System
Common Name:Nd:YAG Laser System
Classification Name:Laser Surgical Instrument, 21 CFR 878.4810.
Legally Marketed
Predicate Device:Profile 1320 Laser System (K022466, K022381)
CoolTouch Nd:YAG Laser System (K031184, K030453
K022817, K014035 and K012982)
Candela Smoothbeam Laser System (K022884, K014128
and K013825)
Description of
Profile 1320 Laser System:Profile 1320 Laser System is an Nd:YAG laser producing
emission at a wavelength of 1320 nm. It consists of a laser
console, internal computer, control panel and displav. an
optical delivery system comprised of an articulated arm
and a handpiece or scanner with cooling capability, and a
footswitch.
Intended Use:The Sciton, Inc. Profile 1320 Laser is intended for use in
general surgery and dermatology for the incision, excision,
ablation, vaporization, coagulation, with hemostasis of soft
tissue. It is indicated for the treatment of fine lines and
wrinkles. It is also indicated for the treatment of back acne
and atrophic acne scars.
Rationale for Substantial
Equivalence:The Profile 1320 Laser System shares the same
indications for use, similar design features (including
wavelength, laser medium, power supply, cooling and
control system), functional features (including power
output, repetition rate, energy, spot size and fluence), and
is therefore substantially equivalent to the above legally
marketed predicate devices.
Safety and Effectiveness
InformationThe indications for use are based upon the indications for
use for predicate systems. Technologically, the Profile
1320 Laser System is substantially equivalent to the listed
predicate devices. Therefore, the risks and benefits for the
Profile 1320 Laser System are comparable to the predicate
devices.
ConclusionThe Profile 1320 shares similar indications for use, design
features, and similar functional features as, and therefore
is substantially equivalent to, the currently marketed
predicate devices.

1

2

Image /page/2/Picture/1 description: The image shows the seal of the Department of Health and Human Services (HHS). The seal features a stylized caduceus, a symbol often associated with medicine and healthcare, consisting of a staff with two snakes coiled around it. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" are arranged in a circular pattern around the caduceus. The seal is black and white and has a simple, clean design.

MAR - 9 2004

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

Mr. Jay M. Patel Director of Regulatory Affairs Sciton, Inc. 845 Commercial Street Palo Alto, California 94303

Re: K032459 Trade/Device Name: Profile 1320 Laser System Regulation Number: 21 CFR 878.4810 Regulation Name: Laser surgical instrument for use in general and plastic surgery and in dermatology Regulatory Class: II Product Code: GEX Dated: December 10, 2003 Received: December 12, 2003

Dear Mr. Patel:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

3

Page 2 - Mr. Jay M. Patel

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 594-4659. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html

Sincerely yours,

Sincerely yours,

Mark N Milliman

Celia M. Witten, Ph.D., M.D. Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

4

Attachment III

Statement of Indications for Use

510(k) Number (if known): ____________________________________________________________________________________________________________________________________________________

Device Name: ___

Frofile 1320 Laser System

Indications for Use:

The Sciton, Inc. Profile 1320 Laser is intended for use in general surgery and dermatology for the incision, excision, ablation, vaporization, coagulation, with hemostasis of soft tissue.

It is indicated for the treatment of fine lines and wrinkles. It is also indicated for the treatment of back acne and atrophic acne scars.

(The indications for use in this paragraph are new per this 510k.)

(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Prescription Use (Per 21CFR801)

OR
Over-The-Counter Use

. Restoral ve. and Neurological Devices

510(k) Number K03245